tetano
Editor, Senior Moderator
Thromb J
. 2022 Oct 6;20(1):61.
doi: 10.1186/s12959-022-00418-7.
Histopathologically TMA-like distribution of multiple organ thromboses following the initial dose of the BNT162b2 mRNA vaccine (Comirnaty, Pfizer/BioNTech): an autopsy case report
Ryo Kaimori[SUP] 1 2 3 [/SUP], Haruto Nishida[SUP] 4 [/SUP], Tomohisa Uchida[SUP] 5 [/SUP], Mari Tamura[SUP] 5 [/SUP], Kohji Kuroki[SUP] 5 [/SUP], Kumi Murata[SUP] 5 [/SUP], Kinta Hatakeyama[SUP] 6 [/SUP], Yoshihiko Ikeda[SUP] 6 [/SUP], Kisaki Amemiya[SUP] 6 [/SUP], Akira Nishizono[SUP] 7 8 [/SUP], Tsutomu Daa[SUP] 9 [/SUP], Shinjiro Mori[SUP] 5 [/SUP]
Affiliations
Abstract
Background: Coronavirus disease 2019 (COVID-19) has spread worldwide. Vaccination is now recommended as one of the effective countermeasures to control the pandemic or prevent the worsening of symptoms. However, its adverse effects have been attracting attention. Here, we report an autopsy case of multiple thromboses after receiving the first dose of the BNT162b2 mRNA vaccine (Comirnaty, Pfizer/BioNTech) in an elderly woman.
Case presentation: A 72-year-old woman with a history of diffuse large B-cell lymphoma in the stomach and hyperthyroidism received the first dose of the BNT162b2 mRNA vaccine and died 2 days later. The autopsy revealed multiple microthrombi in the heart, brain, liver, kidneys, and adrenal glands. The thrombi were CD61 and CD42b positive and were located in the blood vessels primarily in the pericardial aspect of the myocardium and subcapsular region of the adrenal glands; their diameters were approximately 5-40 μm. Macroscopically, a characteristic myocardial haemorrhage was observed, and the histopathology of the characteristic thrombus distribution, which differed from that of haemolytic uraemic syndrome and disseminated intravascular coagulation, suggested that the underlying pathophysiology may have been similar to that of thrombotic microangiopathy (TMA).
Conclusion: This is the first report on a post-mortem case of multiple thromboses after the BNT162b2 mRNA vaccine. The component thrombus and characteristic distribution of the thrombi were similar to those of TMA, which differs completely from haemolytic uraemic syndrome or disseminated intravascular coagulation, after vaccination. Although rare, it is important to consider that fatal adverse reactions may occur after vaccination and that it is vital to conduct careful follow-up.
Keywords: BNT162b2; Coronavirus disease 2019; SARS-CoV-2; Thrombosis; Thrombotic microangiopathy; Vaccination.
. 2022 Oct 6;20(1):61.
doi: 10.1186/s12959-022-00418-7.
Histopathologically TMA-like distribution of multiple organ thromboses following the initial dose of the BNT162b2 mRNA vaccine (Comirnaty, Pfizer/BioNTech): an autopsy case report
Ryo Kaimori[SUP] 1 2 3 [/SUP], Haruto Nishida[SUP] 4 [/SUP], Tomohisa Uchida[SUP] 5 [/SUP], Mari Tamura[SUP] 5 [/SUP], Kohji Kuroki[SUP] 5 [/SUP], Kumi Murata[SUP] 5 [/SUP], Kinta Hatakeyama[SUP] 6 [/SUP], Yoshihiko Ikeda[SUP] 6 [/SUP], Kisaki Amemiya[SUP] 6 [/SUP], Akira Nishizono[SUP] 7 8 [/SUP], Tsutomu Daa[SUP] 9 [/SUP], Shinjiro Mori[SUP] 5 [/SUP]
Affiliations
- PMID: 36203145
- DOI: 10.1186/s12959-022-00418-7
Abstract
Background: Coronavirus disease 2019 (COVID-19) has spread worldwide. Vaccination is now recommended as one of the effective countermeasures to control the pandemic or prevent the worsening of symptoms. However, its adverse effects have been attracting attention. Here, we report an autopsy case of multiple thromboses after receiving the first dose of the BNT162b2 mRNA vaccine (Comirnaty, Pfizer/BioNTech) in an elderly woman.
Case presentation: A 72-year-old woman with a history of diffuse large B-cell lymphoma in the stomach and hyperthyroidism received the first dose of the BNT162b2 mRNA vaccine and died 2 days later. The autopsy revealed multiple microthrombi in the heart, brain, liver, kidneys, and adrenal glands. The thrombi were CD61 and CD42b positive and were located in the blood vessels primarily in the pericardial aspect of the myocardium and subcapsular region of the adrenal glands; their diameters were approximately 5-40 μm. Macroscopically, a characteristic myocardial haemorrhage was observed, and the histopathology of the characteristic thrombus distribution, which differed from that of haemolytic uraemic syndrome and disseminated intravascular coagulation, suggested that the underlying pathophysiology may have been similar to that of thrombotic microangiopathy (TMA).
Conclusion: This is the first report on a post-mortem case of multiple thromboses after the BNT162b2 mRNA vaccine. The component thrombus and characteristic distribution of the thrombi were similar to those of TMA, which differs completely from haemolytic uraemic syndrome or disseminated intravascular coagulation, after vaccination. Although rare, it is important to consider that fatal adverse reactions may occur after vaccination and that it is vital to conduct careful follow-up.
Keywords: BNT162b2; Coronavirus disease 2019; SARS-CoV-2; Thrombosis; Thrombotic microangiopathy; Vaccination.